acute kidney injury - Nursing Case Study
Pathophysiology
• Primary mechanism: Reduced renal perfusion - Acute kidney injury (AKI) often results from decreased blood flow to the kidneys, leading to insufficient oxygen and nutrient delivery. This can be due to conditions like hypotension, heart failure, or severe dehydration, which compromise renal blood flow and subsequently impair kidney function.
• Secondary mechanism: Tubular cell injury - The renal tubules can suffer direct damage from toxins, ischemia, or medications. Damaged tubular cells can obstruct urine flow and cause back-leak of filtrate, further reducing the kidney's ability to filter blood effectively.
• Key complication: Electrolyte imbalances - AKI can lead to imbalances such as hyperkalemia, which affects cardiac function, and metabolic acidosis, impacting cellular activities. Prompt correction and monitoring are crucial to prevent further systemic complications.
Patient Profile
Demographics:
62-year-old male, retired construction worker
History:
• Hypertension, Type 2 Diabetes Mellitus, Chronic Heart Failure
• Metformin, Lisinopril, Furosemide
• Penicillin allergy
Current Presentation:
• Chief complaint: Decreased urine output and fatigue
• Key symptoms: Swelling in legs, confusion, nausea
• Vital signs: Blood pressure 165/95 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, temperature 37.8°C
Section 1
The healthcare team decided to initiate a more thorough assessment of the patient's condition given his presentation of decreased urine output, swelling, and confusion. The initial assessment findings revealed significant pitting edema in both lower extremities, indicating possible fluid overload. Auscultation of the lungs revealed bilateral crackles, suggesting pulmonary congestion, likely secondary to his chronic heart failure exacerbation. The patient's neurological status was also concerning, with the patient displaying confusion and disorientation, which could be attributed to uremic encephalopathy or electrolyte imbalance.
Laboratory results returned with critical values that further explained the patient's deteriorating condition. Serum creatinine was significantly elevated at 4.2 mg/dL, confirming acute kidney injury. Potassium levels were alarmingly high at 6.2 mmol/L, placing the patient at risk for cardiac arrhythmias. Additionally, arterial blood gases indicated a metabolic acidosis with a pH of 7.28, further complicating his clinical picture. The combination of these findings highlighted the severity of the electrolyte imbalances and the need for prompt intervention to prevent further systemic complications.
In response to these findings, the healthcare team prioritized interventions to address the hyperkalemia and metabolic acidosis. Intravenous calcium gluconate was administered to stabilize the cardiac membrane, while insulin and glucose were given to drive potassium back into the cells. Sodium bicarbonate was also considered to address the acidosis. Continuous cardiac monitoring was initiated due to the risk of arrhythmias, and hemodialysis was contemplated as a potential intervention if conservative measures failed to rectify the electrolyte imbalances. Addressing these urgent complications was crucial in stabilizing the patient and preventing further deterioration. The team closely monitored the patient's response to these interventions, ready to adjust the treatment plan based on his evolving clinical status.
Section 2
As the healthcare team closely monitored the patient's response to the initial interventions, some positive changes were noted in his vital signs. His heart rate, which had been erratic, began to stabilize, suggesting that the administration of intravenous calcium gluconate was effective in reducing the immediate risk of cardiac arrhythmias. However, despite these improvements, the patient continued to exhibit significant confusion and disorientation, raising concerns about the persistence of uremic encephalopathy.
New laboratory tests were ordered to assess the efficacy of the treatments. Follow-up serum potassium levels showed a modest decrease to 5.8 mmol/L, indicating partial success in managing the hyperkalemia. However, the pH level remained low at 7.30, demonstrating persistent metabolic acidosis, albeit with slight improvement. These results suggested that while the initial interventions were beneficial, they were insufficient in fully correcting the underlying metabolic disturbances. The healthcare team recognized the need for continued aggressive management of the patient's acid-base balance and renal function.
Meanwhile, the patient's respiratory status became increasingly concerning. His oxygen saturation dropped to 88% on room air, necessitating supplemental oxygen to maintain adequate levels. Repeat auscultation of the lungs revealed worsening crackles and decreased breath sounds at the bases, signifying increased pulmonary congestion. This development prompted a reevaluation of his fluid status and consideration for more advanced renal replacement therapy, such as hemodialysis, to manage both the fluid overload and persistent electrolyte imbalances. The team prepared to initiate dialysis, understanding its potential to provide rapid improvement in the patient's condition by effectively removing excess fluid and toxins from his bloodstream.
Section 3
As the healthcare team initiated hemodialysis, they closely monitored the patient's response to the intervention. Initially, there was optimism as the patient's fluid status began to improve; diuresis was noted, and his blood pressure stabilized at 130/80 mmHg. The supplemental oxygen requirement decreased, and his oxygen saturation improved to 94% with 2 liters of oxygen via nasal cannula. This indicated a positive response to the removal of excess fluid and toxins, suggesting that dialysis was effectively alleviating some of the metabolic burden on his kidneys.
However, shortly after the initiation of dialysis, new complications emerged. The patient developed hypotension, with blood pressure readings plummeting to 90/60 mmHg, accompanied by tachycardia at 110 beats per minute. This sudden change raised concerns of dialysis-induced hypotension, a known complication that can occur due to rapid fluid shifts. The team promptly reduced the ultrafiltration rate and adjusted the patient's dialysate composition to better support his hemodynamic status. Additionally, the patient was placed in a supine position and given a small fluid bolus to counteract the hypotension.
Despite these interventions, the patient's neurological status remained unchanged, with persistent confusion and disorientation. Repeat laboratory tests post-dialysis revealed a further reduction in serum potassium to 4.9 mmol/L, while metabolic acidosis showed slight improvement with a pH level of 7.34. The persistent neurological symptoms, however, suggested that uremic toxins might still be affecting the central nervous system, warranting further investigation and potentially extended dialysis sessions. The team recognized the need for a multidisciplinary approach, including nephrology and neurology consultations, to address these ongoing challenges and optimize the patient's recovery.
Section 4
As the healthcare team continued to manage the patient's care, attention turned to the persistent neurological symptoms. The neurology consultant performed a comprehensive neurological assessment, which revealed subtle myoclonus and asterixis, both indicative of uremic encephalopathy. As such, the neurology team recommended an EEG to assess for any underlying seizures and suggested a brain MRI to rule out structural abnormalities that might be contributing to the patient's confusion and disorientation. Concurrently, nephrology recommended adjusting the dialysis prescription to potentially extend the duration and frequency of sessions to enhance the clearance of uremic toxins.
New diagnostic results provided further insight into the patient's condition. The EEG showed diffuse slowing but no epileptiform activity, which aligned with the clinical picture of metabolic encephalopathy rather than seizure activity. The MRI of the brain revealed no acute intracranial abnormalities, reinforcing the hypothesis that the neurological symptoms were primarily due to metabolic disturbances. Repeat blood work showed that while urea levels had decreased, they remained elevated at 25 mmol/L, suggesting that further dialysis was necessary to clear the accumulated toxins.
In response to these findings, the healthcare team decided to increase the frequency of dialysis sessions to every other day, with careful monitoring of the patient's hemodynamic status to prevent further episodes of hypotension. The team also initiated a trial of lactulose, aiming to reduce ammonia levels, which could be contributing to the encephalopathy. The patient was kept under close observation, with regular mental status checks to assess for any improvement in neurological function. This integrated approach was aimed at optimizing the patient's metabolic environment, with the hope that reducing toxic load would gradually lead to an improvement in his cognitive state.
Section 5
As the healthcare team continued to monitor the patient's response to the adjusted dialysis regimen and lactulose therapy, they observed notable changes in the patient's clinical status. Over the next 48 hours, mental status checks showed a gradual improvement in the patient's cognitive function. The patient, who had previously been disoriented and confused, now demonstrated increased alertness and was able to engage in simple conversation, although occasional episodes of confusion persisted. Vital signs remained stable, with blood pressure consistently above 100/60 mmHg, which indicated that the increased frequency of dialysis sessions had been well-tolerated.
Laboratory results were encouraging, as repeat blood work revealed a further decrease in serum urea levels to 18 mmol/L, and ammonia levels had also decreased significantly. Electrolyte imbalances were closely monitored, and the patient's serum potassium level remained within normal limits at 4.5 mmol/L, reducing concerns about potential cardiac complications. However, despite these positive trends, the patient began to exhibit new symptoms, including mild respiratory distress and a persistent cough. Auscultation revealed bilateral crackles at the lung bases, suggesting the development of fluid overload, a known complication of increased dialysis frequency.
In response to this new development, the healthcare team engaged in clinical reasoning to adjust the patient's management plan. Diuretic therapy was initiated cautiously to address the fluid overload without compromising renal perfusion. Additionally, the dialysis prescription was modified to include ultrafiltration parameters tailored to maximize fluid removal while minimizing hemodynamic instability. The patient's oxygen saturation was monitored closely, and supplemental oxygen was provided as needed to maintain adequate oxygenation. The team remained vigilant for signs of further complications, understanding that the balance between clearing toxins and managing fluid status was delicate, requiring ongoing assessment and timely intervention.